BrightSpring rises 11.1% after stronger-than-expected quarter and raised guidance

What happened

BrightSpring (BTSG) rose 11.1% on October 30, 2026, because it reported third-quarter revenue of $4.2 billion and adjusted EPS of $0.54 and raised full-year guidance, according to GlobeNewsWire and Seeking Alpha. The beat came after management flagged stronger demand and improved operating leverage. The stock opened 8.4% above the previous close and traded at above-average volume as investors reacted to the results and guidance lift.

How big was the move

The session was a company-specific reaction to earnings: trading volume was 2.8 times its 20-day average and the stock’s rise was 4.0 times a typical daily move for this stock. The session left the stock up 11.3% over the last five sessions. The broader market was weaker on the day: the S&P 500 fell 1.8% while the healthcare sector median fell 2.4%, leaving the stock 13.5 percentage points better than its sector median. With a beta of 1.18, the stock tends to move more than the market and this session amplified that tendency.

The technical picture

The stock traded above its key moving averages, sitting 7.9% above its 20-day moving average, 11.6% above its 50-day moving average and 22.3% above its 200-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend, and the stock has spent 313 consecutive trading days above the 200-day average. Shorter-term momentum was strong: the stock rose 16.8% over one month and 10.6% over three months, and it remained 9.3% below its 52-week high. The 14-day Relative Strength Index was 67, within a neutral range between 30 and 70.

Fundamentals and valuation

For the four quarters through September 30, 2026, BrightSpring reported revenue of $15.25 billion, which grew 22.9% from a year earlier, and diluted earnings per share of $1.53, which rose 150.8% year over year. Gross margin was 12.5%, compared with 12.3% a year earlier, and operating margin improved to 3.6% from 2.1% a year earlier. Free-cash-flow margin stood at 3.2%, and return on invested capital was 8.9%. On the balance sheet, the company carried net debt of 2.3 times EBITDA, and share count over one year increased by 1.0%.

Valuation measures showed a price to trailing earnings of 43.7 times trailing earnings and a price to forward earnings of 36.7 times expected earnings, with a free-cash-flow yield of 4.1%. Its price to trailing earnings was lower than 75% of its own readings over the past five years, with a five-year median of 47.9 times earnings.

Earnings and analyst expectations

BrightSpring’s October 30, 2026, result delivered adjusted EPS of $0.54 against $0.47 expected, a surprise of 14.2% above estimates, and marked three consecutive quarters beating estimates. The company reported adjusted EBITDA of $228 million for the quarter, up 42% year over year, and revenue was up 26% year over year. Operating cash flow exceeded $200 million. The average surprise over the last four reports was 14.8% above estimates, and the stock’s typical two-day reaction after recent reports had been a rise of 1.5%. The next report is scheduled for February 26, 2027.

Analysts had a consensus price target of $77.50, which was 15.9% above the closing price on October 30, 2026, based on 12 analysts; all rated the stock Buy or Strong Buy. Investors will be watching whether management’s raised full-year 2026 revenue and adjusted EBITDA guidance is sustained through upcoming quarters.

What to watch

• Full-year 2026 revenue and adjusted EBITDA guidance after the October 30, 2026, report, as raised by the company.
• February 26, 2027, next earnings report date.
• Consensus price target of $77.50, which is 15.9% above the closing price on October 30, 2026, based on 12 analysts.
• PromtFinance scores: Value 89, Growth 90, Momentum 89, Revisions 86, Quality 61, Stability 68.